Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00256048|
Recruitment Status : Completed
First Posted : November 21, 2005
Last Update Posted : April 12, 2017
The purpose of this study is to determine if naso-jejunal feeding (feeding beyond the stomach) improves the efficacy of enteral feeding (feeding into the gut) in critically ill patients.
The study hypothesis is that in patients who fail to establish enteral feeding via the nasogastric route, introduction of nasojejunal feeding will lead to more effective enteral feeding than the current regime involving staged introduction of promotility agents.
|Condition or disease||Intervention/treatment||Phase|
|Critically Ill||Procedure: Nasojejunal feeding||Not Applicable|
The study examines the area of enteral feeding in critically ill patients. Current standard enteral feeding practice is via a nasogastric with the addition of promotility agents for patients who fail to absorb their enteral nutrition.
This study compares the efficacy of nasojejunal feeding feeding with nasogastric enteral feeding with the addition of promotility agents.
The duration of feeding will be determined by the patients nutritional requirements and their general condition. However the data will be collected for duration of enteral feeding, 28 days or ICU discharge whichever occurs first.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||50 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.|
|Study Start Date :||May 2003|
|Actual Study Completion Date :||July 2005|
No Intervention: Standard Care
Patients will receive enteral nutrition via a nasogastric tube as per standard feeding regime
Active Comparator: Nasojejunal Arm
Patient will receive feeding via a nasojejunal feeding tube
Procedure: Nasojejunal feeding
- Efficacy of feeding [ Time Frame: participants will be followed until death, discharge from ICU, commencement of oral or parental nutrition or 28 days post ICU admission ]
- 1. To determine the incidence of complications with enteral feeding via nasogastric and nasojejunal routes. [ Time Frame: participants will be followed until death, discharge from ICU, commencement of parental or oral nutrition or 28 days post ICU admission. ]
- 2. To assess the efficacy of current strategies for optimising enteral feeding efficacy. [ Time Frame: participants will be followed until death, discharge from ICU commencement of oral or parental nutrition,or 28 days post ICU admission. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00256048
|Intensive Care Unit, Royal Melbourne Hospital, Grattan Street|
|Parkville, Victoria, Australia, 3050|
|Principal Investigator:||Megan Robertson||Intensive Care Unit, Royal Melbourne Hospital|